CAD 0.11
(-12.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.16 USD | 60.0% |
2022 | -0.40 USD | 59.18% |
2021 | -0.98 USD | -157.89% |
2020 | -0.38 USD | -137.5% |
2019 | -0.16 USD | -233.33% |
2018 | 0.12 USD | 49.07% |
2017 | 0.08 USD | 1119.7% |
2016 | 0.01 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.07 USD | -13.94% |
2024 Q1 | -0.06 USD | -3.18% |
2023 Q2 | 0.02 USD | -59.27% |
2023 FY | - USD | 60.0% |
2023 Q4 | -0.06 USD | 40.2% |
2023 Q3 | -0.10 USD | -600.0% |
2023 Q1 | 0.05 USD | 120.46% |
2022 Q1 | -0.06 USD | 94.71% |
2022 FY | - USD | 59.18% |
2022 Q4 | -0.24 USD | -50.0% |
2022 Q3 | -0.16 USD | -197.95% |
2022 Q2 | -0.05 USD | 9.29% |
2021 FY | - USD | -157.89% |
2021 Q1 | -0.10 USD | 9.36% |
2021 Q4 | -1.12 USD | -17130.77% |
2021 Q3 | -0.01 USD | 83.12% |
2021 Q2 | -0.04 USD | 61.38% |
2020 Q2 | -0.13 USD | -18.18% |
2020 Q1 | -0.11 USD | 21.43% |
2020 Q4 | -0.11 USD | -133.55% |
2020 FY | - USD | -137.5% |
2020 Q3 | -0.05 USD | 63.77% |
2019 Q2 | 0.02 USD | -33.33% |
2019 Q1 | 0.03 USD | 32.16% |
2019 FY | - USD | -233.33% |
2019 Q4 | -0.14 USD | -937.04% |
2019 Q3 | -0.01 USD | -167.5% |
2018 Q2 | 0.04 USD | 20.36% |
2018 Q1 | 0.03 USD | 96.47% |
2018 Q3 | 0.02 USD | -50.25% |
2018 FY | - USD | 49.07% |
2018 Q4 | 0.02 USD | 13.5% |
2017 Q2 | 0.02 USD | -14.04% |
2017 FY | - USD | 1119.7% |
2017 Q1 | 0.02 USD | 0.0% |
2017 Q4 | 0.02 USD | -22.02% |
2017 Q3 | 0.02 USD | 42.48% |
2016 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Aurora Cannabis Inc. | -1.60 CAD | 90.0% |
Avicanna Inc. | -0.09 CAD | -71.858% |
Avant Brands Inc. | -0.61 CAD | 73.77% |
Cardiol Therapeutics Inc. | -0.44 CAD | 63.636% |
Crescita Therapeutics Inc. | -0.10 CAD | -63.265% |
Knight Therapeutics Inc. | -0.16 CAD | -0.0% |
MediPharm Labs Corp. | -0.04 CAD | -344.444% |
OrganiGram Holdings Inc. | -2.82 CAD | 94.326% |
Canopy Growth Corporation | -8.79 CAD | 98.18% |
Willow Biosciences Inc. | -0.10 CAD | -60.0% |
Auxly Cannabis Group Inc. | -0.04 CAD | -256.347% |